MARKET

COLL

COLL

Collegium Pharmaceutical Inc
NASDAQ
33.25
+0.02
+0.06%
After Hours: 33.08 -0.17 -0.51% 18:24 03/25 EDT
OPEN
33.48
PREV CLOSE
33.23
HIGH
33.76
LOW
33.20
VOLUME
635.13K
TURNOVER
--
52 WEEK HIGH
50.79
52 WEEK LOW
23.23
MARKET CAP
1.06B
P/E (TTM)
19.17
1D
5D
1M
3M
1Y
5Y
1D
Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million
The Motley Fool · 16h ago
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Medline (MDLN) and Collegium Pharmaceutical (COLL)
TipRanks · 1d ago
Weekly Report: what happened at COLL last week (0316-0320)?
Weekly Report · 2d ago
Collegium Pharmaceutical (COLL) Valuation Check After Recent Share Price Volatility
Simply Wall St · 3d ago
Collegium Pharmaceutical EVP and General Counsel David Dieter disposes of USD 488,219 in common shares
Reuters · 5d ago
Collegium Pharmaceutical: Another M&A Episode Adds To An Intriguing Case
Seeking Alpha · 5d ago
Collegium Pharmaceutical Expands ADHD Portfolio With AZSTARYS And Valuation Gap
Simply Wall St · 5d ago
Jefferies Keeps Their Buy Rating on Collegium Pharmaceutical (COLL)
TipRanks · 5d ago
More
About COLL
Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company. The Company has developed, licensed, and acquired a portfolio of products for use in the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. Its commercial products include Jornay PM (Jornay), Belbuca, Xtampza ER (Xtampza), Nucynta ER and Nucynta IR (Nucynta Products), and Symproic in the United States. Its Jornay is a central nervous system (CNS) stimulant prescription medicine for the treatment of ADHD. The Belbuca is a buccal film that contains buprenorphine for severe and persistent pain. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. The Xtampza ER is a pain treatment option designed with abuse deterrent properties. The Nucynta Products are ER and IR oral formulations of tapentadol. Nucynta ER is indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic.

Webull offers Collegium Pharmaceutical Inc stock information, including NASDAQ: COLL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COLL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COLL stock methods without spending real money on the virtual paper trading platform.